Skip to content
Download PDF

Telomere Disease

Chapter 482 | Part 16: Genes, the Environment, and Disease · Parts 15-16 – Genetics, Genomics & Precision Medicine · Chapter 482

Key Clinical Points

  1. Telomeropathies are caused by germline loss-of-function mutations in genes involved in telomere maintenance, leading to accelerated telomere attrition.
  2. Dyskeratosis Congenita (DC) is the classic presentation, characterized by a mucocutaneous triad: reticular skin pigmentation, oral leukoplakia, and nail dystrophy.
  3. Bone marrow failure (aplastic anemia) is the most common major manifestation of telomere disease.
  4. Pulmonary fibrosis occurs in ≈ 20% of DC cases; 10–15% of patients with idiopathic pulmonary fibrosis (IPF) or familial pulmonary fibrosis have underlying telomere defects.
  5. Telomere length measurement (Flow-FISH or qPCR) is a top predictor for diagnosis; 'short' is defined as <10th percentile and 'very short' as <1st percentile.
  6. Long Telomere Syndrome (LTS) is caused by POT1 mutations, leading to excessively long telomeres (>99th percentile), clonal hematopoiesis, and tumor predisposition.
  7. Liver disease (cirrhosis, nodular regenerative hyperplasia, NAFLD, or HCC) can be a primary or secondary manifestation of telomere defects.
  8. Genetic testing via next-generation sequencing (NGS) is the definitive method for identifying mutations in genes such as TERT, TERC, DKC1, and RTEL1.
  9. Environmental factors (smoking, alcohol, viral infection) increase susceptibility to organ damage in patients with telomere defects.
  10. Telomere testing is not recommended for assessing aging or longevity in the general population.

DEFINITION & OVERVIEW

• Telomeropathies: Defined as diseases characterized by pathologic accelerated telomere attrition resulting from germline mutations in genes involved in telomere maintenance. • Pathophysiology of Attrition:

Harrison's Definition: Pathologic accelerated telomere attrition has a genetic origin. Germ-line loss-of-function mutations in genes involved in telomere biology impair telomere length repair, increasing the rate of telomere erosion from highly proliferative cells, reaching critically short lengths fast. • Consequences of Attrition: → Inadequate repair/protection → accelerated erosion → cell death, deficient cell proliferation, and chromosome instability. → Affected tissues show defective regeneration, fibrosis, or replacement by fat. → High-Risk Organs: Bone marrow (high demand for blood cell production), lungs (exposed to environmental toxins), liver (high proliferative capacity), and skin.

Molecular Mechanism

• Telomere Structure: → Physical termini of linear chromosomes. → Composed of hundreds to thousands of TTAGGG tandem repeats (leading strand) and CCCTAA (lagging strand). → Protected by the shelterin complex (TRF1, TRF2, TIN2, POT1, TPP1, RAP1). • End-Replication Problem: → DNA polymerase requires an RNA primer; its removal leaves a gap at the end of linear DNA. → Telomeres buffer the loss of genetic information during mitosis. • Cellular Response: → Critically short telomeres → trigger p53 pathway → proliferative arrest and apoptosis (the 'Hayflick phenomenon'). → If cells bypass arrest → activation of DNA damage repair → chromosome end-to-end fusions, breaks, aneuploidy, and instability.

ETIOLOGY & PATHOPHYSIOLOGY

• Genetic Architecture: → Genetics: At least 17 genes implicated in telomere biology. → Inheritance: X-linked, autosomal recessive (AR), and autosomal dominant (AD). → Penetrance: Highly variable even within a single pedigree; asymptomatic carriers may have subclinical organ dysfunction (e.g., reduced FVC, hypocellular marrow, hepatic steatosis). → Allelic Status: Often monoallelic (haploinsufficiency) in TERT, TERC, and RTEL1. → Triallelic Inheritance: Occurs when mutations are present in two genes within the same pathway (common in DC). → Somatic Rescue: Rare spontaneous genetic events that can mitigate the phenotype of a germline mutation. → Clonal Hematopoiesis: May be maladaptive; associated with mutations in genes like TP53.

Gene-Specific Pathology

• Dyskeratosis Congenita (DC): → Classic telomere disease of childhood/early adulthood. → Mucocutaneous Triad: Reticular skin pigmentation, oral leukoplakia, and nail dystrophy. → Severe Syndromes: Cerebellar hypoplasia (Hoyeraal-Hreidarsson syndrome) or exudative retinopathy (Revesz syndrome). • Long Telomere Syndrome (LTS): → Caused by heterozygous germline loss-of-function mutations in the POT1 gene. → Result: Excessively long telomeres → increased capacity for cell proliferation → acquisition of harmful driver somatic mutations → clonal hematopoiesis and tumor predisposition. • Pulmonary Fibrosis: → 20% of DC cases; 10–15% of patients with idiopathic pulmonary fibrosis (IPF) or familial pulmonary fibrosis have underlying telomere defects. → Associated finding: Pulmonary arteriovenous malformation leading to right-to-left shunting.

CLINICAL FEATURES

• Dyskeratosis Congenita (DC): → Presentation: Typically diagnosed in the first two decades of life. → Bone Marrow Failure: Most common major manifestation; often presents as moderate aplastic anemia with macrocytic mild-to-moderate anemia/thrombocytopenia and preserved leukocyte numbers. → Pulmonary Fibrosis: Occurs in ≈ 20% of cases. → Liver Disease: Occurs in 10% of cases, often following bone marrow transplant for hematopoietic failure. • Aplastic Anemia (AA): → Common in patients with telomere defects without typical mucocutaneous stigmata. → Myeloid Neoplasms: Patients with MDS or AML and a family history of bone marrow failure may have underlying telomere defects (classified as 'myeloid neoplasms associated with telomere biology disorders'). • Pulmonary Fibrosis: → Clinical Presentation: Often indistinguishable from IPF in the general population. → Specific Features: Cryptic hepatic cirrhosis, macrocytosis, cytopenias, and family history of lung/liver/bone marrow disease. → Imaging/Testing: Restrictive pattern (decreased DLCO) on PFT; 'honeycomb' appearance on HRCT; histopathology shows interstitial pneumonia. • Liver Disease: → Manifestations: Hepatic cirrhosis, nodular regenerative hyperplasia, nonalcoholic fatty liver disease (NAFLD), and hepatocellular carcinoma (HCC). → Mechanism: Short telomeres limit hepatocyte proliferation during injury; susceptibility to alcohol and viral infections is increased.

Clinical Presentation Summary

• Mucocutaneous Triad: Reticular skin pigmentation, oral leukoplakia, nail dystrophy. • Pulmonary Findings: Restrictive pattern (decreased DLCO), 'honeycomb' appearance on HRCT, interstitial pneumonia.

DIFFERENTIAL DIAGNOSIS

• Bone Marrow Failure: → Acquired vs. Inherited: Telomere length is a top predictor in machine-learning tools to differentiate acquired immune aplastic anemia from inherited bone marrow failure syndromes. → MDS/AML: Distinguish from telomere biology disorders based on family history and telomere length. • Pulmonary Fibrosis: → IPF vs. Telomere-related: Suspect telomere defect if there is a family history of lung, liver, or bone marrow disease; presence of macrocytosis or hepatic cirrhosis suggests telomere defect.

Liver Disease

• Cirrhosis: May be the sole presentation; distinguish from viral/alcohol-associated cases by checking for telomere mutations.

DIAGNOSTIC APPROACH

  1. Telomere Length Measurement: • Methods: Flow-FISH (determines length in individual cells/subpopulations) or qPCR (measures average length in population). • Interpretation of Results: → Reported as kilobases (kb) adjusted for age. → <10th percentile → "short". → <1st percentile → "very short" (highly suggestive of DC). → >99th percentile → "very long" (suggestive of LTS). • Note: Results may be confounded by circulating immature cells, which may have very short telomeres.
  2. Genetic Testing: • Indication: Triggered when telomere length is "short" or "very short". • Method: Next-generation sequencing (NGS) for genes including TERT, TERC, DKC1, and RTEL1. • Interpretation: Use in silico analysis, mutation location, and functional studies to resolve variants of unknown significance.

MANAGEMENT & TREATMENT

  1. Bone Marrow Failure: • Supportive Care: Transfusions for cytopenias. • Definitive Treatment: Bone marrow transplant for severe aplastic anemia.
  2. Pulmonary Fibrosis: • Monitoring: Monitor for respiratory failure; monitor forced vital capacity and DLCO. • Imaging: High-resolution computed tomography (HRCT) to assess fibrosis.
  3. Liver Disease: • Prevention: Avoid alcohol and viral infections where possible. • Monitoring: Monitor for cirrhosis and hepatocellular carcinoma.
  4. Long Telomere Syndrome: • Monitoring: Monitor for clonal hematopoiesis and tumor development.

Clinical Pearls

• Environmental Factors: Smoking, alcohol, and viral infections increase risk of organ damage in carriers. • Screening: Patients with MDS/AML and family history of bone marrow failure should be screened for telomere defects.

COMPLICATIONS & PROGNOSIS

• Malignancy Risk: → Long Telomeres: Increase capacity for cell proliferation → facilitate acquisition of harmful driver somatic mutations. → Myeloid Neoplasms: Associated with telomere biology disorders (WHO classification). • Organ Failure: → Pulmonary: Potential for right-to-left shunting via pulmonary arteriovenous malformation. → Liver: Risk of cirrhosis and HCC exacerbated by environmental stressors.

SPECIAL CONSIDERATIONS

• General Population: → Telomere testing is NOT recommended for assessing aging or longevity. → Telomere length does not determine the necessity for therapeutic intervention in the absence of a genetic diagnosis.

Clinical Pitfalls

• Interpretation: Do not interpret telomere shortening as a result of aging unless a specific mutation is identified. • Confounding Factors: Be aware that circulating immature cells can skew qPCR results.

KEY PEARLS & HIGH-YIELD POINTS

• Diagnostic Rule: Telomere length is a top predictor in machine-learning tools to differentiate acquired immune aplastic anemia from inherited bone marrow failure. • Key Genes: TERT, TERC, DKC1, RTEL1 (short); POT1 (long). • Clinical Rule: If pulmonary fibrosis is accompanied by macrocytosis, cytopenias, and a family history of liver/bone marrow disease → suspect telomere defect.

Reference Tables

TABLE 482-1 Genetic Variants in 13 Genes Involved in Telomere Maintenance, Inheritance Pattern, and Phenotype GENE…

Harrison's 22e, p.3820

GENE DYSKERATOSIS
CONGENITA		 APLASTIC
ANEMIA		 PULMONARY
FIBROSIS		 CIRRHOSIS MDS/LEUKEMIA
Telomerase
DKC1 XL
TERT AD/AR AD/AR AD AD AD/AR
TERC AD/AR AD AD AD AD
NOP10 AR
NHP2 AR
WRAP53 AR
Shelterin
AD AD AD
AD
AD
Others
RTEL1 AR AD/AR AD AD
CTC1 AR AR
PARN AD
USB1 AD
ZCCHC8 AD AD
NAF1 AD